|
SulfamylonDrug - Sulfamylon The trade name of the product as shown on the labeling.
Dosage -
FOR SOLUTION; TOPICAL
Active Ingredient(s) -
Mafenide Acetate
Strength -
5%
Applicant -
MYLAN BERTEK
New Drug Application (NDA) Number -
019832
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Jun 5, 1998
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Mylan Bertek Pharmaceuticals Inc
Sulfamylon
Sulfamylon 5% For Solution; Topical
Loxitane Eq 25mg Base Capsule; Oral Loxitane Eq 50mg Base Capsule; Oral Loxitane Eq 5mg Base Capsule; Oral Loxitane Eq 10mg Base Tablet; Oral Loxitane Eq 25mg Base Tablet; Oral Loxitane Eq 50mg Base Tablet; Oral Luveris 75 Iu/vial Injectable; Subcutaneous Diapid 0.185mg/ml Solution; Nasal Sulfamylon Eq 85mg Base/gm Cream; Topical NewDrugInformation |